Pharma Jogot
The country’s leading pharma manufacturer Beximco Pharmaceuticals Ltd makes a foray into the Australian Pharma market with the launch of Pantoprazole, a drug for treating gastrointestinal disorders. This is the first time pharmaceutical product from Bangladesh is being exported to Australia.
The first consignment has been delivered recently and to mark this auspicious occasion, and to celebrate this milestone achievement, a brief ceremony was held at the company’s factory premises in the presence of the Australian High Commissioner to Bangladesh, His Excellency Greg Wilcock. He was accompanied by Minhaz Chowdhury, Country Manager, Australian Trade Commission. Beximco Pharma Chief Operating Officer Rabbur Reza received the delegation at the factory premises located in Tongi while other senior officials from the company as well as representatives from Singapore Airlines and Capital Logistics were present on this occasion.
The delegation was briefed about the company which currently has the highest number of global accreditations in the sector. Following the ceremony, the High Commissioner also visited the state-of-the-art manufacturing facilities of Beximco Pharma and he was highly impressed with the world-class manufacturing practices in its operation. He hoped that with the commencement of pharmaceutical export, business and cooperation between the two countries will continue to expand and reach new heights in the coming days.
It is worth mentioning that Beximco Pharmaceuticals Ltd. is a leading exporter of medicines in the country and its state-of-the-art manufacturing facilities have been certified by global regulatory authorities such as TGA Australia, AGES Austria (for European Union), Health Canada, ANVISA Brazil, INVIMA Colombia and TFDA (Taiwan), among others.
Beximco Pharmaceuticals Limited founded in 1976 and based in Dhaka, Bangladesh, Beximco Pharma manufactures and sells generic pharmaceutical formulation products and active pharmaceutical ingredients. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies. The Company operates from a 23-acre site in Dhaka and has manufacturing facilities for producing various drugs in different delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, prefilled syringes, injectables, nebulizer solutions, oral soluble films etc. Ensuring access to quality medicines is the powerful aspiration that motivates the 3,000 employees of the Company.
Beximco Pharma’s state-of-the-art manufacturing facilities are certified by global regulatory authorities of Australia, the European Union, and Brazil, among others. The Company’s products are sold to retail outlets, medical institutions, and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia, and Myanmar, and in other markets overseas, principally in Africa, including Mauritius, Kenya, Ghana and Nigeria, Pacific Island, Latin & Central American countries, Middle East, Central Asia, South East Asia, including Singapore, Malaysia, Philippines & Hong Kong, and Europe & Austria.